SCHEMBL3392653

SCHEMBL3392653

COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC1CCN(C=CC=O)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.73
ERBB2 P04626 7/20 0.64
FBP1 P09467 2/20 0.64
KDR P35968 2/20 0.64
KDM4E B2RXH2 1/20 0.64
GAK O14976 1/20 0.64
MAPK13 O15264 1/20 0.64
ABL1 P00519 1/20 0.64
CYP1A2 P05177 1/20 0.64
CDK1 P06493 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2D6 P10635 1/20 0.64
MAPT P10636 1/20 0.64
CYP2C9 P11712 1/20 0.64
SRC P12931 1/20 0.64
TSHR P16473 1/20 0.64
MAPK1 P28482 1/20 0.64
EPHB2 P29323 1/20 0.64
CYP2C19 P33261 1/20 0.64
MAPK12 P53778 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3433015 0.90 EGFR (0.62) EGFRERBB2KDREPHA2
SCHEMBL3391872 0.90 EGFR (0.73) EGFRERBB2FBP1KDRKDM4E
SCHEMBL3389265 0.89 EGFR (0.60) EGFRERBB2MAPK14
SCHEMBL3395371 0.89 EGFR (0.65) EGFRERBB2MAPK13MAPK12MAPK11
SCHEMBL3390805 0.89 EGFR (0.76) EGFRERBB2
SCHEMBL3431548 0.88 EGFR (0.66) EGFRERBB2FBP1KDRGAK
SCHEMBL3395092 0.88 EGFR (0.74) EGFRERBB2KDREPHA2
SCHEMBL3390863 0.87 ERBB2 (0.74) EGFRERBB2KDREPHA2
SCHEMBL3395689 0.87 EGFR (0.61) EGFRERBB2KDREPHA2
SCHEMBL3391878 0.87 EGFR (0.63) EGFRERBB2KDREPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2167492-A2 NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS Hanmi Pharm. Co., Ltd. (KR) 2010-03-31 EP disclosed
WO-2008150118-A2 NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS HANMI PHARM. CO., LTD. (KR) 2008-12-11 WO disclosed